2023-06-02 06:18:35 ET
- Hemostemix ( OTCQB:HMTXF ) to launch a non-brokered private placement of up to 10M units priced at $0.12 each, closing in tranches.
- Each unit will consist of one share and one-half of a share purchase warrant, with each full warrant entitling the holder to acquire one common share at a price of $0.25/common share for a period of 24 months from the closing of the offering.
- "This facility enables Hemostemix to maintain control of its formulation of ACP-01 and produce it at approximately 1/12 th the cost per batch quoted by contract manufacturers," stated Thomas Smeenk, CEO.
For further details see:
Hemostemix to raise $1.2M through private placement of units